Table 4.
Patient characteristics and documented HBV monitoring and management
| Characteristic | All Patients (N=1,727) |
|---|---|
| Age (mean ± SD), Years | 51 ± 12 |
| Male gender (N, (%)) | 926 (54) |
| Race/Ethnicity (N, (%)) | |
| Asian/ Pacific Islander | 1,164 (67) |
| Caucasian | 220 (13) |
| African-American | 206 (12) |
| Hispanic/Latino | 93 (5) |
| Other | 44 (3) |
| Patients Uninsured | 649 (38) |
| HAV screening performed (N, (%)) | 1,398 (81) |
| Received HAV vaccination (N, (%)) | 420 (24) |
| HCV screening performed (N, (%)) | 597 (35) |
| HIV screening performed (N, (%)) | 417 (24) |
| ALT measurement performed (N, (%)) | 1,646 (95) |
| Most recent ALT measurement within 12 months (N, (%)) | 1,291 (75) |
| ALT levels (median (min-max)) | 28 (10–193) |
| HBV viral load measurement (N, (%)) | 813 (47) |
| HBV DNA ≥2000 IU/mL | 326 (40) |
| HBV Viral Load Measurement within 12 months (N, (%)) | 413 (24) |
| HBeAg testing (N, (%)) | |
| HBeAg Negative | 1,024 (59) |
| HBeAg Positive | 207 (12) |
| Not Performed | 496 (29) |
| Most recent HBeAg test within 12 months (N, (%)) | 363 (21) |
| AFP measurement performed (N, (%)) | 1,100 (64) |
| Abdominal imaging (N, (%)) | |
| None | 1,142 (66) |
| Ultrasound | 348 (20) |
| CT | 235 (14) |
| MRI | 2 (0.1) |
| Combination of imaging studies | 410 (24) |
| Any HCC screening within 12 months (N, (%)) | 847 (51%) |